{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:30:49Z","timestamp":1762867849327},"reference-count":19,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2019,5,31]]},"DOI":"10.5582\/irdr.2019.01061","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T22:03:27Z","timestamp":1560463407000},"page":"138-141","source":"Crossref","is-referenced-by-count":7,"title":["Tumefactive fibroinflammatory lesion successfully treated with Rituximab"],"prefix":"10.5582","volume":"8","author":[{"given":"Jessica L","family":"Bishop","sequence":"first","affiliation":[{"name":"Medical College of Georgia at Augusta University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Locke J.","family":"Bryan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Georgia Cancer Center at Augusta University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha M.","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Hematopathology\/Hematology, Medical College of Georgia at Augusta University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Kenneth","family":"Byrd","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery, Medical College of Georgia at Augusta University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Alyono JC, Shi Y, Berry GJ, Recht LD, Harsh GR 4th, Jackler RK, Corrales CE. Inflammatory pseudotumors of the skull base: Meta-analysis. Otol Neurotol. 2015; 36:1432-1438.","DOI":"10.1097\/MAO.0000000000000818"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Desai SV, Spinazzi EF, Fang CH, Huang G, Tomovic S, Liu JK, Baredes S, Eloy JA. Sinonasal and ventral skull base inflammatory pseudotumorA systematic review. Laryngoscope. 2015; 125:813-821.","DOI":"10.1002\/lary.24993"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Narla LD, Newman B, Spottswood, S, Narla S, Kolli R. Inflammatory Pseudotumor. Radiographics. 2003; 23:719-729.","DOI":"10.1148\/rg.233025073"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hoebers FJ, Ordonez BP, Irish J, Simpson RE, Yu E, O'Sullivan B. Progressive tumefactive fibroinflammatory lesion of the infratemporal fossa treated by radiation therapy. Rare Tumors. 2012; 4:e12.","DOI":"10.4081\/rt.2012.e12"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kusaka S, Nishimura S, Kawakami F, Ohbayashi C, Shibuya Y, Iwata K. Tumefactive fibroinflammatory lesion presenting with head and neck fibrosclerosing lesions and orbital pseudotumors: A case report. J Med Case Rep. 2013; 7:260.","DOI":"10.1186\/1752-1947-7-260"},{"key":"6","unstructured":"6. Jain P, Sen R, Sharma N, Bhargava S, Singh V. Tumefactive fibroinflammatory lesion: A diagnostic dilemma. Iran J Med Sci. 2017; 42:205-209."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kansara S, Bell D, Johnson J, Zafereo M. Head and neck inflammatory pseudotumor: Case series and review of the literature. Neuroradiol J. 2016; 29:440-446.","DOI":"10.1177\/1971400916665377"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Garcia BA, Tinsley S, Schellenberger T, Bobustuc GC. Recurrent inflammatory pseudotumor of the jaw with perineural intracranial invasion demonstrating sustained response to rituximab. Med Oncol. 2012; 29:2452-2455.","DOI":"10.1007\/s12032-011-0128-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ortlip TE, Drake VE, Raghavan P, Papadimitriou JC, Porter NC, Eisenman DJ, Hertzano R. Inflammatory pseudotumor of the temporal bone: A case series. Otol Neurotol. 2017; 38:1024-1031.","DOI":"10.1097\/MAO.0000000000001465"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schafranski MD. Idiopathic orbital inflammatory disease successfully treated with rituximab. Clin Rheumatol. 2009; 28:225-226.","DOI":"10.1007\/s10067-008-1040-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kasi SK, Kim HJ, Basham RP, Cunningham ET Jr, Sy A, Lustig L, Kersten RC. Idiopathic orbital inflammation associated with necrotizing scleritis and temporal bone inflammation. Ophthalmic Plast Reconstr Surg. 2016; 32:e77-e79.","DOI":"10.1097\/IOP.0000000000000251"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tian H, Liu T, Wang C, Tang L, Chen Z, Xing G. Inflammatory pseudotumor of the temporal bone: Three cases and a review of the literature. Case Rep Med. 2013; 2013:480476.","DOI":"10.1155\/2013\/480476"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Berta AI, Agaimy A, Braun JM, Manger B, Kruse FE, Holbach L. Bilateral orbital IgG4-related disease with systemic and corneal involvement showing an excellent response to steroid and rituximab therapy: Report of a case with 11 years follow-up. Orbit. 2015; 34:299-301.","DOI":"10.3109\/01676830.2015.1057290"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wu A, Andrew NH, Tsirbas A, Tan P, Gajdatsy A, Selva D. Rituximab for the treatment of IgG4-related orbital disease: Experience from five cases. Eye (Lond). 2015; 29:122-128.","DOI":"10.1038\/eye.2014.251"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Barnado AL, Cunningham MA. IgG4-related disease presenting as recurrent mastoiditis with central nervous system involvement. J Investig Med High Impact Case Rep. 2014; 2. pii: 2324709614553670.","DOI":"10.1177\/2324709614553670"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Klastersky J. Adverse effects of the humanized antibodies used as cancer therapeutics. Curr Opin Oncol. 2006; 18:316-320.","DOI":"10.1097\/01.cco.0000228734.32261.62"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001; 33:289-294.","DOI":"10.1097\/00004836-200110000-00006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Min KH, Rhee CK, Jung JY, Suh MW. Characteristics of adverse effects when using high dose short term steroid regimen. Korean J Audiol. 2012; 16:65-70.","DOI":"10.7874\/kja.2012.16.2.65"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Poetker DM., Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngology Clin N Am. 2010; 43:753-768.","DOI":"10.1016\/j.otc.2010.04.003"}],"container-title":["Intractable & Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/8\/2\/8_2019.01061\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T03:34:58Z","timestamp":1560569698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/8\/2\/8_2019.01061\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2019.01061","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,31]]}}}